{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:18:36Z","timestamp":1791512316726,"version":"4.3.4"},"reference-count":35,"publisher":"Massachusetts Medical Society","issue":"13","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1056\/nejmoa2607973","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:35:07Z","timestamp":1785350107000},"page":"1299-1309","source":"Crossref","is-referenced-by-count":8,"title":["Phase 3 Trial of Weekly Oral Islatravir\u2013Lenacapavir for HIV-1 Treatment"],"prefix":"10.1056","volume":"395","author":[{"given":"J\u00fcrgen K.","family":"Rockstroh","sequence":"first","affiliation":[{"name":"Department of Medicine I, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moti N.","family":"Ramgopal","sequence":"additional","affiliation":[{"name":"Midway Immunology and Research Center, Fort Pierce, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Curran F\u00e0bregas","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Hedgcock","sequence":"additional","affiliation":[{"name":"Spectrum Health, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Workowski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Ronot-Bregigeon","sequence":"additional","affiliation":[{"name":"H\u00f4pital Sainte-Marguerite, Aix-Marseille Universit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Cassetti","sequence":"additional","affiliation":[{"name":"Helios Salud, Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Brinson","sequence":"additional","affiliation":[{"name":"Central Texas Clinical Research, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir K.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6877-5345","authenticated-orcid":false,"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"East Sydney Doctors, Darlinghurst, NSW, Australia"},{"name":"Taylor Square Private Clinic, Surry Hills, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Slim","sequence":"additional","affiliation":[{"name":"New York Medical College, Valhalla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[{"name":"Japan Institute for Health Security, National Center for Global Health and Medicine, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Shalit","sequence":"additional","affiliation":[{"name":"Peter Shalit MD and Associates, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie O.","family":"Klopfer","sequence":"additional","affiliation":[{"name":"Merck, Rahway, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Shihadeh","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Patel","sequence":"additional","affiliation":[{"name":"Merck, Rahway, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene\u00e9-Claude","family":"Mercier","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"Merck, Rahway, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Dvory-Sobol","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"SenGupta","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Llamoso","sequence":"additional","affiliation":[{"name":"Merck, Rahway, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Rhee","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6168-6745","authenticated-orcid":false,"given":"Chloe","family":"Orkin","sequence":"additional","affiliation":[{"name":"SHARE Collaborative, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu046"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2014.945601"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-024-00657-w"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-023-00572-6"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00051-6"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy247"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04423-x"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26099"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03817-z"},{"key":"e_1_3_5_11_2","unstructured":"Marcotullio S Spire B Garcia D et al. EU patient experience and views on antiretroviral treatment \u2014 findings from the positive perspectives survey. Presented at the 16th European AIDS Conference Milan October 25\u201327 2017."},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30372-8"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13048"},{"key":"e_1_3_5_14_2","unstructured":"Highlights of prescribing information: Idvynso (doravirine\/islatravir). Rahway NJ: Merck April 2026 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2026\/216964Orig1s000lbl.pdf)."},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115542"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2443-1"},{"key":"e_1_3_5_17_2","unstructured":"Highlights of prescribing information: Sunlenca (lenacapavir). Foster City CA: Gilead Sciences November 2024 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215973s006 215974s008lbl.pdf)."},{"key":"e_1_3_5_18_2","unstructured":"Sunlenca (lenacapavir). Amsterdam: European Medicines Agency August 25 2022 (https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sunlenca)."},{"key":"e_1_3_5_19_2","unstructured":"Highlights of prescribing information: Yeztugo (lenacapavir). Foster City CA: Gilead Sciences June 2025 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/220020s000lbl.pdf)."},{"key":"e_1_3_5_20_2","unstructured":"Yeytuo (lenacapavir): summary of product characteristics. Amsterdam: European Medicines Agency September 3 2025 (https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/yeytuo)."},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00334-24"},{"key":"e_1_3_5_22_2","unstructured":"European AIDS Clinical Society. EACS guidelines v13.0. October 2025 (https:\/\/eacs.sanfordguide.com\/)."},{"key":"e_1_3_5_23_2","unstructured":"Center for Drug Evaluation and Research. Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment. Guidance for industry. Washington DC: Food and Drug Administration November 2015 (https:\/\/www.fda.gov\/files\/drugs\/published\/Human-Immunodeficiency-Virus-1-Infection--Developing-Antiretroviral-Drugs-for-Treatment.pdf)."},{"key":"e_1_3_5_24_2","unstructured":"Colson AE Kumar PN Ruane PJ et al. Once-weekly oral islatravir\/lenacapavir (ISL\/LEN) versus daily standard-of-care therapy in virologically suppressed adults with HIV-1: week 48 results of the ISLEND-2 phase 3 trial. Presented at the 26th International AIDS Conference Rio de Janeiro July 26\u201331 2026."},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(24)00030-4"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf077"},{"key":"e_1_3_5_27_2","unstructured":"Squires KE Correll TA Robertson MN et al. Effect of islatravir on total lymphocyte and lymphocyte subset counts. Presented at the Conference on Retroviruses and Opportunistic Infections Seattle February 19\u201322 2023."},{"key":"e_1_3_5_28_2","unstructured":"Colson AE Crofoot G Ruane P et al. Once-weekly islatravir plus lenacapavir maintains HIV-1 suppression through 96 weeks: phase 2 study. Presented at the Conference on Retroviruses and Opportunistic Infections Denver February 22\u201325 2026."},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-25-01939"},{"key":"e_1_3_5_30_2","unstructured":"ClinicalInfoHIV.gov. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. September 25 2025 (https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new)."},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(25)00096-7"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1287-z"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834380c1"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115009"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf368"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf087"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2607973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:00:44Z","timestamp":1790802044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2607973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10,1]]}},"alternative-id":["10.1056\/NEJMoa2607973"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2607973","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}